2022

1. A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma

   Clinical cancer research : an official journal of the American Association for Cancer Research

2. FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

   Blood Advances, Vol. 6, Núm. 2, pp. 690-703

3. Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting

   Cancers, Vol. 14, Núm. 18